Evidence map›Paper›PMID 39277579›Full record

ArticleNature communications2024

Dual client binding sites in the ATP-independent chaperone SurA.

Bob Schiffrin, Joel A Crossley, Martin Walko, Jonathan M Machin, G Nasir Khan, Iain W Manfield, Andrew J Wilson, David J Brockwell, Tomas Fessl, Antonio N Calabrese and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bob Schiffrin *Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-1670-7356
Joel A Crossley *Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-6656-1578
Martin WalkoAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-7160-6136
Jonathan M MachinAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
G Nasir KhanAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Iain W ManfieldAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0003-3765-0325
Andrew J WilsonAstbury Centre for Structural Molecular Biology, School of Chemistry, University of Leeds, Leeds, UK.ORCID 0000-0001-9852-6366
David J BrockwellAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-0802-5937
Tomas FesslFaculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
Antonio N CalabreseAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0003-2437-7761
Sheena E RadfordAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK. s.e.radford@leeds.ac.uk.ORCID 0000-0002-3079-8039
Anastasia ZhuravlevaAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK. a.zhuravleva@leeds.ac.uk.ORCID 0000-0001-6165-8509

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T000635/1Wellcome Trust 220628Wellcome Trust 220628/Z/20/ZWellcome Trust 222373/Z/21/ZWellcome Trust (Wellcome) 094232/Z/10/ZWellcome Trust (Wellcome) 105615/Z/14/Z
6 · The paper itself

Abstract

The ATP-independent chaperone SurA protects unfolded outer membrane proteins (OMPs) from aggregation in the periplasm of Gram-negative bacteria, and delivers them to the β-barrel assembly machinery (BAM) for folding into the outer membrane (OM). Precisely how SurA recognises and binds its different OMP clients remains unclear. Escherichia coli SurA comprises three domains: a core and two PPIase domains (P1 and P2). Here, by combining methyl-TROSY NMR, single-molecule Förster resonance energy transfer (smFRET), and bioinformatics analyses we show that SurA client binding is mediated by two binding hotspots in the core and P1 domains. These interactions are driven by aromatic-rich motifs in the client proteins, leading to SurA core/P1 domain rearrangements and expansion of clients from collapsed, non-native states. We demonstrate that the core domain is key to OMP expansion by SurA, and uncover a role for SurA PPIase domains in limiting the extent of expansion. The results reveal insights into SurA-OMP recognition and the mechanism of activation for an ATP-independent chaperone, and suggest a route to targeting the functions of a chaperone key to bacterial virulence and OM integrity.

Indexed as

Carrier ProteinsEscherichia coliEscherichia coli ProteinsMolecular ChaperonesPeptidylprolyl IsomeraseAdenosine TriphosphateATP-Binding Cassette TransportersBacterial Outer Membrane ProteinsBinding SitesFluorescence Resonance Energy TransferModels, MolecularProtein BindingProtein DomainsProtein FoldingAdenosine TriphosphateATP-Binding Cassette TransportersBacterial Outer Membrane ProteinsCarrier ProteinsEscherichia coli ProteinsMolecular ChaperonesPeptidylprolyl IsomeraseSurA protein, E coli

Identifiers

PMID39277579
PMCPMC11401910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.